AliveCor has introduced a new portable 12-lead, AI-powered ECG device, the Kardia 12L ECG System, which has received dual FDA approval. This innovative AI-powered device is capable of detecting 35 cardiac conditions, including heart attacks, using a reduced leadset. The Kardia 12L is small enough to fit into a pocket, making it a significant advancement in mobile cardiac monitoring. This launch marks a milestone for AliveCor, which has been involved in a patent dispute with Apple.
Thank you @statnews for highlighting our dual FDA clearance of the world's first AI to detect 35 cardiac conditions, including heart attack, using a reduced leadset, alongside our innovative Kardia 12L ECG System, powered by this breakthrough AI. https://t.co/vJUmqN9Eie https://t.co/K0n9UJsliz
AI-powered cardia care benefiting millions! A huge milestone for the @AliveCor team https://t.co/KSO7lNSByr https://t.co/gEqTRDdbVr
World's first ECG AI that can detect heart attack on a device small enough to fit into your pocket . Also includes 35 other cardiac conditions!!! https://t.co/0EDcflwIpe
World's first ECG AI that can detect heart attack on a reduced leadset along with 35 other cardiac conditions! https://t.co/0EDcflwIpe
AliveCor introduces the world's first AI that can detect heart attack on a reduced leadset in monumental dual clearance by the FDA. Today, AliveCor launched the all-new, AI-powered Kardia 12L ECG System, which is FDA-cleared to detect 35 cardiac conditions including serious… https://t.co/u6gbnXwllF
@AliveCor changes the cardiac monitor game once again—receive FDA approval for mobile 12-lead, AI-powered ECG machine https://t.co/YSOSGP0t9n
AliveCor, which has been embroiled in a patent dispute with Apple, has a new product: A portable 12-lead, AI-powered ECG device. @mariojoze has all the details: https://t.co/SVoGv9nXCD via @statnews